DeepVerge has today announced a significant further step toward it becoming a key supplier to a national long-term COVID early-warning solution.
Being part of an as yet unnamed government’s COVID Infrastructural Trial, DeepVerge has today received orders amounting to £480,000 for its newly enhanced monitoring equipment. This multiplex development trial, which will facilitate automated real-time and remote wastewater monitoring and pathogen detection, is expected to last until the end of February 2022, during which time the Group will continue to collect ongoing servicing/consultancy fees.
Recognising that regulatory enforcement is likely to require domestic water authorities to replace their existing manual sampling process with one capable of delivering instantaneous results combined with predictive analysis from the billions of litres being generated daily, prospective demand (plus ongoing maintenance) for networked installations of Microtox® PD equipment both from this government and other international territories could become very large indeed.
(Please note that TPI’s valuation is based on financial modelling and there is no guarantee that such a valuation will ever be realised, therefore please do not base investment decisions on this valuation alone. Also please note that past performance is not a reliable indicator of future results.)
We would draw your attention to the various disclaimers in the document both at the beginning and at the end of the note. Retail clients (as defined by the rules of the FCA) must not rely on the research document. In particular you should note that the research document is a non-independent marketing communication. The analyst who has prepared the research is aware that TPI provides research to DeepVerge plc. Accordingly the research has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibitions on dealing ahead of its dissemination.
The information in the document is published solely for information purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. The material contained in the document is general information intended for recipients who understand the risks associated with equity investment in smaller companies. It does not constitute a personal recommendation as defined by the FCA or take into account the particular investment objectives, financial situation or needs of individual investors nor provide any indication as to whether an investment, a course of action or the associated risks are suitable for the recipient.
Copyright © 2021 Turner Pope Investments (TPI) Limited, all rights reserved.
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
Terms of Website Use
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned